Cue Biopharma, Inc. (CUE)

Every FINRA and SEC series the site collects for Cue Biopharma, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.

Download CSV

327K

Short interest

settlement 2026-08-14

1.6

Days to cover

-6.4% vs prior

45.8%

Short share of volume

2026-09-11

549

Fails to deliver

settlement 2026-08-14

-$2.0M

Insider flow, 90 days

0 buys, 11 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in CUE is 327,442 shares, up 19,551 shares over the last month. Over the last 48 readings it ranged from 255,157 shares (15 May 2026) to 7,541,901 shares (15 April 2026). The latest reading sits at the bottom of that range. At the reported average volume of 201K shares a day that is 1.6 days to cover.

Embed this chartfree, with the attribution line it carries

<iframe src="https://xoomar.com/embed/stocks/cue" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-08-14	327,442	-6.4%	200,890	1.63
2026-07-31	349,876	+13.6%	184,644	1.89
2026-07-15	307,891	+3.3%	138,660	2.22
2026-06-30	298,077	+8.4%	111,200	2.68
2026-06-15	274,983	-1.0%	73,707	3.73
2026-05-29	277,694	+8.8%	107,168	2.59
2026-05-15	255,157	-11.7%	2,034,085	1.00
2026-04-30	288,887	-96.2%	533,660	1.00
2026-04-15	7,541,901	+183.1%	44,894,553	1.00
2026-03-31	2,664,499	+17.2%	3,385,101	1.00
2026-03-13	2,272,639	+27.6%	1,059,938	2.14
2026-02-27	1,781,535	-10.0%	293,366	6.07
2026-02-13	1,978,661	-8.6%	438,687	4.51
2026-01-30	2,165,317	+16.8%	2,055,161	1.05
2026-01-15	1,853,300	+28.6%	1,823,121	1.02
2025-12-31	1,440,523	+290.6%	2,165,183	1.00
2025-12-15	368,757	-16.5%	311,764	1.18
2025-11-28	441,825	-13.3%	181,939	2.43
2025-11-14	509,612	+39.6%	569,375	1.00
2025-10-31	365,072	+6.1%	186,331	1.96
2025-10-15	344,086	-44.6%	361,781	1.00
2025-09-30	620,911	-6.8%	173,490	3.58
2025-09-15	665,931	-25.9%	129,012	5.16
2025-08-29	898,157	-6.1%	126,769	7.08

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of CUE volume is 45.8%, down 3.8 points over the last five sessions. Over the last 52 readings it ranged from 27.5% (10 August 2026) to 76.6% (16 July 2026). The latest reading is in line with the 30-session average of 45.9%, on 63K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-09-11	29K	63K	45.8%	0
2026-09-10	34K	53K	64.0%	0
2026-09-09	36K	71K	50.2%	247
2026-09-08	69K	135K	51.3%	0
2026-09-04	10K	24K	42.7%	0
2026-09-03	10K	21K	49.6%	253
2026-09-02	24K	49K	47.9%	715
2026-09-01	49K	86K	56.8%	5,084
2026-08-31	20K	35K	55.5%	38
2026-08-28	17K	39K	42.3%	0
2026-08-27	46K	103K	44.4%	493
2026-08-26	35K	88K	40.4%	48
2026-08-25	39K	88K	43.7%	1,575
2026-08-24	25K	62K	41.0%	0
2026-08-21	47K	74K	63.8%	1,701
2026-08-20	43K	74K	58.1%	9,531
2026-08-19	31K	82K	38.0%	3,782
2026-08-18	64K	106K	59.8%	1,870
2026-08-17	77K	153K	50.1%	12,023
2026-08-14	22K	65K	33.8%	2,993
2026-08-13	41K	111K	37.1%	4,631
2026-08-12	29K	104K	27.5%	0
2026-08-11	68K	230K	29.4%	0
2026-08-10	41K	148K	27.5%	0
2026-08-07	12K	24K	50.6%	0
2026-08-06	31K	72K	42.8%	0
2026-08-05	23K	60K	39.1%	0
2026-08-04	33K	81K	41.1%	286
2026-08-03	32K	65K	49.5%	6,451
2026-07-31	133K	247K	53.7%	50,578

Fails to deliver

SEC, by settlement date. JSON

As of 14 August 2026, the fails-to-deliver balance in CUE is 549 shares, up 518 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (29 June 2026) to 1,503,120 shares (8 April 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-08-14	549	$31.08	$17K
2026-08-13	31	$30.42	$943
2026-08-10	1,792	$27.12	$49K
2026-08-06	561	$26.65	$15K
2026-08-05	4,002	$26.60	$106K
2026-08-04	2,303	$26.87	$62K
2026-08-03	2,382	$26.84	$64K
2026-07-31	32,305	$30.40	$982K
2026-07-30	4	$28.01	$112
2026-07-28	2,979	$32.57	$97K
2026-07-27	8,724	$32.12	$280K
2026-07-24	6,758	$33.09	$224K
2026-07-23	283	$34.20	$10K
2026-07-22	2,258	$33.46	$76K
2026-07-21	478	$30.95	$15K
2026-07-20	661	$31.16	$21K
2026-07-15	1,865	$31.28	$58K
2026-07-13	1,037	$36.78	$38K
2026-07-10	1,362	$36.51	$50K
2026-07-09	9,598	$35.35	$339K
2026-07-08	42,144	$33.39	$1.4M
2026-07-07	33,782	$32.50	$1.1M
2026-07-02	21	$28.34	$595
2026-07-01	67	$31.56	$2K
2026-06-30	2,874	$30.43	$87K
2026-06-29	1	$25.39	$25
2026-06-26	2,468	$25.54	$63K
2026-06-25	118	$26.01	$3K
2026-06-22	1,240	$28.46	$35K
2026-06-18	3,845	$26.73	$103K

Insider trades

SEC Form 4, newest first. JSON

Insiders at CUE reported 11 open-market sells worth $2.0M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Meluzio Michael Vincent (VP, Prin. Accounting Officer) on 2026-08-13.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-08-13	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Sell	3	$31.13	$93	49K
2026-08-13	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Sell	4K	$30.35	$125K	49K
2026-08-13	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Sell	2K	$29.37	$45K	53K
2026-08-13	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Option exercise	14K	$0.00	$0	55K
2026-08-13	Ray Sumita	Chief Legal Compliance Officer	Sell	4	$31.13	$125	119K
2026-08-13	Ray Sumita	Chief Legal Compliance Officer	Sell	6K	$30.35	$196K	119K
2026-08-13	Ray Sumita	Chief Legal Compliance Officer	Sell	2K	$29.37	$70K	125K
2026-08-13	Ray Sumita	Chief Legal Compliance Officer	Option exercise	18K	$0.00	$0	127K
2026-08-13	Lin Shao-Lee	Chief Executive Officer	Sell	10K	$29.48	$308K	706K
2026-08-13	Lin Shao-Lee	Chief Executive Officer	Sell	2K	$28.11	$67K	716K
2026-08-13	Lin Shao-Lee	Chief Executive Officer	Sell	5K	$27.19	$147K	719K
2026-08-12	Lin Shao-Lee	Chief Executive Officer	Sell	6K	$27.75	$160K	724K
2026-08-12	Lin Shao-Lee	Chief Executive Officer	Sell	34K	$26.99	$924K	730K
2026-08-12	Lin Shao-Lee	Chief Executive Officer	Option exercise	109K	$0.00	$0	764K
2026-07-30	Ahlers James M	Chief Financial Officer	Grant	26K	$0.00	$0	26K
2026-07-13	Borie Dominique Christian	Chief Medical Officer	Grant	32K	$0.00	$0	32K
2026-07-09	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Grant	41K	$0.00	$0	41K
2026-07-09	Meehan Viola Mong	n/a	Grant	22K	$0.00	$0	22K
2026-07-09	Sarraf Pasha	n/a	Grant	22K	$0.00	$0	33K
2026-07-09	Garzone Pamela	n/a	Grant	22K	$0.00	$0	22K
2026-07-09	Lin Shao-Lee	Chief Executive Officer	Grant	328K	$0.00	$0	655K
2026-07-09	Ray Sumita	Chief Legal Compliance Officer	Grant	55K	$0.00	$0	109K
2026-07-09	Camardo Daniel A.	n/a	Grant	22K	$0.00	$0	22K
2026-05-03	Lin Shao-Lee	CHIEF EXECUTIVE OFFICER	Grant	328K	$0.00	$0	328K
2025-12-30	Sarraf Pasha	n/a	Buy	77K	$0.30	$23K	324K
2025-12-30	Sarraf Pasha	n/a	Buy	78K	$0.31	$24K	246K
2025-12-30	Sarraf Pasha	n/a	Buy	87K	$0.32	$28K	168K
2025-12-30	Sarraf Pasha	n/a	Buy	77K	$0.30	$23K	81K
2025-12-30	Sarraf Pasha	n/a	Buy	4K	$0.31	$1K	4K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Planned sales (Form 144)

Newest first. JSON

1 Form 144 notice on file for CUE worth $266K at the prices reported; 1 in the last 90 days worth $266K. Latest: Sumita Ray filed on 2026-08-13 to sell 8,829 shares ($266K) from 2026-08-13.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-08-13	Sumita RayOfficer, CORPORATE SECRETARY	9K	$266K	0.122%	2026-08-13	Maxim Group LLC

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

1 holder above 5% has filed on CUE, 1 on Schedule 13D (active intent). The largest reported stake is Shao-Lee Lin at 6.2% of the class (467,166 shares), filed 2026-08-21 for an event on 2026-05-03.

Filed	Form	Holder	Shares	Of class	Event
2026-08-21	13D	Shao-Lee Linindividual	467K	6.2%	2026-05-03

13F holders

Tracked managers holding CUE at their latest 13F. JSON

2 of the 30 tracked managers held CUE at their latest 13F, $1.3M in total at quarter-end prices. Citadel Advisors is the largest at $809K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 1 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Citadel Advisors	2026-06-30	26K	$809K	0.00%	+13K
Renaissance Technologies	2026-06-30	15K	$464K	0.00%	-199K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Cue Biopharma, Inc. in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows Cue Biopharma, Inc. (CUE), SEC CIK 1645460, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest: FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
Planned sales: SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-13.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-21.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Insider trades: SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-13.JSON and CSV
Company record: EDGAR filing index for CIK 1645460Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of CUE is sold short?

327,442 shares were held short at the 2026-08-14 settlement, 1.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is CUE's daily short volume?

On 2026-09-11, 29,024 of the 63,422 CUE shares reported to FINRA were sold short, 45.8% of the day's reported volume. Short volume is a flow for one day, not a position.

Does CUE have fails to deliver?

The SEC's latest file shows 549 CUE shares failed to deliver at settlement 2026-08-14. Fails are reported per settlement date and published twice a month with a lag.

Are CUE insiders buying or selling?

Have CUE insiders filed to sell?

1 Form 144 notice on file for CUE worth $266K at the prices reported; 1 in the last 90 days worth $266K. Latest: Sumita Ray filed on 2026-08-13 to sell 8,829 shares ($266K) from 2026-08-13.

Who owns more than 5% of CUE?

1 holder above 5% has filed on CUE, 1 on Schedule 13D (active intent). The largest reported stake is Shao-Lee Lin at 6.2% of the class (467,166 shares), filed 2026-08-21 for an event on 2026-05-03.

Which funds hold CUE?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Cue Biopharma, Inc. (CUE)

Short interest

Daily short volume

Fails to deliver

Insider trades

Planned sales (Form 144)

Large holders (13D and 13G)

13F holders

Cue Biopharma, Inc. in the regulatory record

Source and method

How to read it

Other company pages

Datasets

Frequently Asked Questions